Managing pitted keratolysis through hyperhidrosis control with topical glycopyrrolate 2% - 22/08/19
Sidiropoulou P., Department of Dermatology, Hyperhidrosis Clinic, “A. Sygros” Hospital for Skin Diseases, University of Athens, Greece; Gregoriou S., Department of Dermatology, Hyperhidrosis Clinic, “A. Sygros” Hospital for Skin Diseases, University of Athens, Greece; Balaskas E., Department of Dermatology, Hyperhidrosis Clinic, “A. Sygros” Hospital for Skin Diseases, University of Athens, Greece; Platsidaki E., Department of Dermatology, Hyperhidrosis Clinic, “A. Sygros” Hospital for Skin Diseases, University of Athens, Greece; Tzanetakou V., Department of Dermatology, Hyperhidrosis Clinic, “A. Sygros” Hospital for Skin Diseases, University of Athens, Greece; Markantoni V., Department of Dermatology, Hyperhidrosis Clinic, “A. Sygros” Hospital for Skin Diseases, University of Athens, Greece; Agiasofitou E., Department of Dermatology, Hyperhidrosis Clinic, “A. Sygros” Hospital for Skin Diseases, University of Athens, Greece; Rigopoulos D., Department of Dermatology, Hyperhidrosis Clinic, “A. Sygros” Hospital for Skin Diseases, University of Athens, Greece; Kontochristopoulos G., Department of Dermatology, Hyperhidrosis Clinic, “A. Sygros” Hospital for Skin Diseases, University of Athens, Greece
Le texte complet de cet article est disponible en PDF.| Commercial support: None identified. |
Vol 81 - N° 4S1
P. AB91 - octobre 2019 Retour au numéro
Article précédent
- Management of patients with difficult-to-treat psoriasis in Africa and the Middle East
- Mapping cutaneous T-cell lymphoma in the state of Florida
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?